The Canadian Covid Society is among a group of concerned stakeholders who are advocating for broader access to diverse COVID-19 vaccine options across Canada.

We have co-signed a letter to the Public Health Agency of Canada, all the provinces/territories, and immunization providers to address the pressing need for enhanced COVID-19 vaccination awareness and education, and increased availability and access to the protein-based Novavax vaccine.

Key issues highlighted include:

  1. Access Issues: Many Canadians face significant challenges in accessing the Novavax COVID-19 vaccine due to systemic barriers, long travel distances, and inconsistent information from government and healthcare providers.
  2. Educational and Awareness Gaps: There is a significant lack of public awareness regarding the need for ongoing COVID-19 vaccination, particularly additional (booster) doses.
  3. Communication Breakdown: Effective communication between healthcare providers, public health officials, and the public is crucial. Reports of conflicting advice and misinformation from healthcare providers diminish public trust and impede vaccination efforts.
  4. Trust-Building: Public skepticism towards vaccines, fueled by mixed messages and perceived politicization, must be addressed through transparent communication and community engagement.

CIAN Novovax_Eng

Read the full letter here.

Follow us

Stay up to date on the latest news, information, and resources.